71 related articles for article (PubMed ID: 8572638)
1. Infiltrating ductal carcinoma of the breast: extensive intraductal component has no impact on lymph node involvement and survival.
Joura EA; Lösch A; Kainz C; Sam C; Joura EM; Gitsch G; Dadak C; Breitenecker G
Anticancer Res; 1995; 15(5B):2285-6. PubMed ID: 8572638
[TBL] [Abstract][Full Text] [Related]
2. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
3. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
4. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
[TBL] [Abstract][Full Text] [Related]
5. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
7. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
8. Node-related factors and survival in node-positive breast carcinomas.
Sivridis E; Giatromanolaki A; Galazios G; Koukourakis MI
Breast; 2006 Jun; 15(3):382-9. PubMed ID: 16135406
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
10. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].
Paumier A; Sagan C; Campion L; Fiche M; Andrieux N; Dravet F; Pioud R; Classe JM
J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):529-34. PubMed ID: 14593298
[TBL] [Abstract][Full Text] [Related]
11. Influence of the in situ component in 389 infiltrating ductal breast carcinomas.
Carabias-Meseguer P; Zapardiel I; Cusidó-Gimferrer M; Godoy-Tundidor S; Tresserra-Casas F; Rodriguez-García I; Fábregas-Xauradó R; Xercavins-Montosa J
Breast Cancer; 2013 Jul; 20(3):213-7. PubMed ID: 22271067
[TBL] [Abstract][Full Text] [Related]
12. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
[TBL] [Abstract][Full Text] [Related]
13. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ
Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458
[TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
15. Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast.
Romero L; Klein L; Ye W; Holmes D; Soni R; Silberman H; Lagios MD; Silverstein MJ
Am J Surg; 2004 Oct; 188(4):371-6. PubMed ID: 15474428
[TBL] [Abstract][Full Text] [Related]
16. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
17. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy.
Nixon AJ; Schnitt SJ; Gelman R; Gage I; Bornstein B; Hetelekidis S; Recht A; Silver B; Harris JR; Connolly JL
Cancer; 1996 Oct; 78(7):1426-31. PubMed ID: 8839547
[TBL] [Abstract][Full Text] [Related]
18. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
Pierga JY; Mouret E; Diéras V; Laurence V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Vincent-Salomon A; Scholl S; Extra JM; Asselain B; Pouillart P
Br J Cancer; 2000 Dec; 83(11):1480-7. PubMed ID: 11076657
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer in women aged 35 and under: prognosis and survival.
Jmor S; Al-Sayer H; Heys SD; Payne S; Miller I; Ah-See A; Hutcheon A; Eremin O
J R Coll Surg Edinb; 2002 Oct; 47(5):693-9. PubMed ID: 12463710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
